What does Genhem do?
GENHEM is a biotechnology company specializing in advanced genetic engineering and gene therapy. The company focuses on developing innovative solutions for genetic disorders and enhancing agricultural productivity through its cutting-edge technologies. By leveraging its expertise in genomics, GENHEM aims to improve health outcomes and contribute to sustainable food production.
- Signals
-
Poor liquidityPoor liquidity 0.03
The current ratio is below 1: may be insufficient to cover short-term debt.
ProfitableProfitable € 529KThe company reported a positive net result in the latest financial year.
Strong equityStrong equity € 3.10MStrong equity provides a buffer against setbacks.
Low riskLow risk 37.5%Good solvency (> 30%) points to long-term financial stability.
Positive cashflowPositive cashflow € 529KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 359KPositive EBITDA: operating activities are profitable.
- Shareholders
- Hewijli 100%
- Investments
- Hemmar - Pvc 100%, Niedic 35,19%
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2026
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
360K
|
€
461K
|
€
105K
|
€
579K
|
|
|
€
359K
|
€
460K
|
€
105K
|
€
579K
|
|
|
€
529K
|
€
603K
|
€
536K
|
€
844K
|
|
|
€
3.10M
|
€
3.09M
|
€
2.94M
|
€
2.90M
|
|
|
37.47%
|
35.52%
|
34.58%
|
47.55%
|
|
|
€
5.17M
|
€
5.61M
|
€
5.56M
|
€
3.20M
|
|
|
€
63K
|
€
12K
|
€
41K
|
€
119K
|
Publications 33
All publications- Ontslagen - Benoemingen 05/09/2023
- Doel - Ontslagen - Benoemingen - Boekjaar 31/01/2022
- Ontslagen - Benoemingen 22/02/2019
- Ontslagen - Benoemingen 17/10/2016
- Me. - Jaarrekening 31.12.2015, Ggk 25.06.2016, Ngl 30.08.2016 16545-0248-014 09/09/2016
Frequently asked questions
Answers to the most common questions about Genhem, based on official government data and the filed annual accounts.
What is the VAT number of Genhem?
The VAT number of Genhem is BE0453.938.026.
When was Genhem established?
Genhem was founded in 02-12-1994.
What is the official address of Genhem?
The official address of Genhem is Guido Gezellestraat 130 Beersel 1654.
What is the legal form of Genhem?
The juridical form of Genhem is Public limited company (NV/SA).
What is the annual revenue of Genhem?
The 2026 accounts of Genhem do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Genhem do?
GENHEM is a biotechnology company specializing in advanced genetic engineering and gene therapy. The company focuses on developing innovative solutions for genetic disorders and enhancing agricultural productivity through its cutting-edge technologies. By leveraging its expertise in genomics, GENHEM aims to improve health outcomes and contribute to sustainable food production.
Is Genhem a reliable company?
Genhem is a registered Rechtspersoon with company number 0453.938.026 and can be verified through the official CBE database.
What is the credit limit of Genhem?
The estimated credit limit of Genhem is €443,597.
Is Genhem still active?
Genhem currently has the status "Normal situation" and is active.